Amosulalol

This classification denotes an adrenergic antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C69JI1BAU8. European Medicines Agency schedules Amosulalol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05478MIG. Amosulalol generally arises in the molecular formula C18H24N2O5S. The term AMOSULALOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24.) AMOSULALOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amosulalol under HS 29350090 and SITC 51580. As of Q4 2014, AMOSULALOL remains the US FDA Preferred Term for this commodity. Amosulalol bears US NLM identifiers UMLS ID C0103116 and NCI Concept Code C72916. SMILES: S(=O)(=O)(N)C1CC(C(O)CNCCOC2C(OC)CCCC2)CCC1C.